![](/img/cover-not-exists.png)
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies
Federico, Sara M., Pappo, Alberto S., Sahr, Natasha, Sykes, April, Campagne, Olivia, Stewart, Clinton F., Clay, Michael R., Bahrami, Armita, McCarville, Mary B., Kaste, Sue C., Santana, Victor M., HelVolume:
137
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.06.014
Date:
September, 2020
File:
PDF, 1003 KB
2020